← Leaderboards
Richard D Lopez
University Of Alabama At Birmingham
$2,859,414
Attributed
$2,859,414
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $563.1K · FY2007–11$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,859,414 · 3
By mechanism
P50$1,642,663 · 1
R01$815,707 · 1
R21$401,044 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Craig A Elmets$8,601,504
- Max D Cooper$23,641,392
- John Michael Ruppert$5,190,544
- Ralph R Weichselbaum$16,065,057
- Seah H Lim$2,778,286
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaApoptosisGrowthDefectFundingGrantCancer PatientBlood CellsCell TransformationClinical Trials DesignEpithelialAntigensGenerationsCancer CellCancer TherapyAutoantigensAutologousAnimal ModelBaseCellsBiologicalClinical TrialsDoseDesign
Grant awards (11)
Gamma Delta T Cell Immunotherapy of Breast Cancer$326,444
P50 · FY2011 · CA · contact PI
Therapeutic antitumor and antiviral potential of allogeneic gamma-delta T cells$181,294
R21 · FY2011 · AI · contact PI
Gamma Delta T Cell Immunotherapy of Breast Cancer$343,392
P50 · FY2010 · CA · contact PI
Therapeutic antitumor and antiviral potential of allogeneic gamma-delta T cells$219,750
R21 · FY2010 · AI · contact PI
Gamma Delta T Cell Immunotherapy of Breast Cancer$343,144
P50 · FY2009 · CA · contact PI
Gamma Delta T Cell Immunotherapy of Breast Cancer$324,240
P50 · FY2008 · CA · contact PI
Gamma Delta T Cell Immunotherapy of Breast Cancer$305,443
P50 · FY2007 · CA · contact PI
Gamma Delta T Cells--Immunotherapy for Melanoma$238,569
R01 · FY2004 · CA
Gamma Delta T Cells--Immunotherapy for Melanoma$238,569
R01 · FY2003 · CA
Gamma Delta T Cells--Immunotherapy for Melanoma$100,000
R01 · FY2003 · CA
Gamma Delta T Cells--Immunotherapy for Melanoma$238,569
R01 · FY2002 · CA